Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2010
10/21/2010US20100266613 Anti-tnf-alpha antibodies and their uses
10/21/2010US20100266605 Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect
10/21/2010US20100266595 Treatment of insulin-resistant disorders
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266564 Polyunsaturated Fatty Acid Synthase Nucleic Acid Molecules and Polypeptides, Compositions, and Methods of Making and Uses Thereof
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266528 Systemic Administration of Colony Stimulating Factors to Treat Amyloid Associated Disorders
10/21/2010US20100266526 Combination therapy for treating hypercholesterolemia
10/21/2010US20100266490 Metalloproteinase Binding Proteins
10/21/2010CA2761064A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010CA2758948A1 Method for the induction of a reward response by modulation of dopaminergic systems in the central nervous system
10/21/2010CA2758934A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010CA2758929A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010CA2758918A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010CA2758854A1 High fiber nutritional emulsions for blood glucose control
10/21/2010CA2758852A1 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010CA2758745A1 Compounds affecting glycemic index
10/21/2010CA2758588A1 Methods of reduction of interpatient variability
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2757711A1 Microrna as a biomarker of pancreatic islet beta-cell engagement
10/21/2010CA2755392A1 Pharmaceutical compositions
10/20/2010EP2241575A1 Methods of treating obesity with combination therapeautics of igf-1 fusion polypeptides
10/20/2010EP2241567A1 Bicycloamine derivative
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2241561A1 Neuroprotective, hypocholesterolemic and antiepileptic compound
10/20/2010EP2241328A1 Interleukin-1 inhibitors in the treatment of diseases
10/20/2010EP2241327A1 Mixtures of Amylin and Insulin
10/20/2010EP2241326A1 Pharmaceutical compositions and methods for insulin treatment
10/20/2010EP2241313A1 Use of flavonoids to increase the bioavailability of hesperetin
10/20/2010EP2241197A1 Agent and edible material for inhibiting body fat accumulation
10/20/2010EP2241195A1 A method and composition for nutritionally improving glucose control and insulin action
10/20/2010EP2240501A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue
10/20/2010EP2240474A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/20/2010EP2240448A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/20/2010EP2240447A2 Morpholine derivates as antiobesity agents
10/20/2010EP2240440A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs
10/20/2010EP2240439A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
10/20/2010EP2240438A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
10/20/2010EP2240198A1 Composition for absorption through mucous tissue
10/20/2010EP2240182A1 Treating hyperglycemia with 25-hydroxyvitamin d3
10/20/2010EP2240155A2 Devices, formulations, and methods for delivery of multiple beneficial agents
10/20/2010EP1966199B1 Azaindole-2-carboxamide derivatives
10/20/2010EP1921065B1 Phenylpyridone derivative
10/20/2010EP1747778B1 Anti-fatigue composition
10/20/2010EP1699759B1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/20/2010EP1414496B1 Pharmaceutical composition containing a combinaition of ppar-alpha, pravastatin and polyglycolized glyceride
10/20/2010EP1360508B1 Prediction of wound healing by urinary nitrate assay
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2010CN101868459A Pyridin-2 -yl-amino-1, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/20/2010CN101868251A Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/20/2010CN101868238A Composition comprising sesamin component and vitamin B1 component
10/20/2010CN101868237A Alpha7 nAChR agonists for treating or preventing metabolic disorders
10/20/2010CN101868235A Compositions and methods for inhibiting the activation of dsRNA-dependent protein kinase and tumor growth inhibition
10/20/2010CN101868226A Composition for controlling lipase catalyzed reactions
10/20/2010CN101868156A Citrulline-containing drink
10/20/2010CN101864375A Lactobacillu plantarurn with function of reducing cholesterol and application thereof
10/20/2010CN101863971A Metastin derivatives and use thereof
10/20/2010CN101863939A Method for preparing complanatoside A
10/20/2010CN101863903A 1,4-dihydrobithiophene [3', 2': 5, 6] bithiapyran [4, 3-c] pyrazol-3-carboxylic acid derivative and application thereof
10/20/2010CN101863891A Trifluoromethane triazolidine quinoxaline derivative and preparation method thereof
10/20/2010CN101863888A Medicaments with HM74a receptor activity
10/20/2010CN101863886A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/20/2010CN101863872A Method for extracting PiPerlonguminine and drug combination comprising same
10/20/2010CN101863755A Chromium malate complex and preparation method and application thereof
10/20/2010CN101862628A Biodegradable microencapsulated capsaicine and preparation method thereof
10/20/2010CN101862501A Medicine bag containing taxus chinensis leaves and taxus chinensis leaf treating and processing devices
10/20/2010CN101862446A SOD (Super Oxide Dismutase) grape health care wine
10/20/2010CN101862445A Oral insulin containing protease inhibitor
10/20/2010CN101862413A Chinese medicinal preparation for treating type-2 diabetes and preparation method thereof
10/20/2010CN101862412A Chinese olive blood-sugar reducing tea
10/20/2010CN101862397A Medicinal liquor
10/20/2010CN101862372A Method for purifying flavones in mulberry leaves
10/20/2010CN101862371A Method for preparing flavone and alkaloid from mulberry leaves
10/20/2010CN101862369A Perilla and Rhodiola rosea capsules
10/20/2010CN101862367A Cassia seed soft capsule for reducing fat and losing weight and preparation method
10/20/2010CN101862348A Compound containing turtle serum and application thereof
10/20/2010CN101862346A Hypoglycemic application of gingseng acidic polysaccharide
10/20/2010CN101862345A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
10/20/2010CN101862318A Combined medicament-combined linolenic acid capable of preventing and fundamentally treating thromboembolic diseases
10/20/2010CN101862309A Glipizide sustained-release capsule and preparation method thereof
10/20/2010CN101862301A Tartraric rosiglitazone sustained release tablet and preparation method thereof
10/20/2010CN101862300A Lovastatin dispersible tablet and preparation method thereof
10/20/2010CN101862274A Skincare product compound containing folic acid and preparation method thereof
10/20/2010CA2663327A1 Methods and compositions for promoting the neurological development of an infant
10/19/2010US7816557 Glucagon receptor antagonists, preparation and therapeutic uses
10/19/2010US7816539 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816528 Preparation of aminopyrimidine compounds
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816397 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010US7816342 Anti-obesity compositions
10/19/2010US7816325 secondary binding site of dipeptidyl peptidase IV, its relationship amongst substrates and to the modulation of substrate specificity of dipeptidyl peptidase IV (DP IV, synonym: DPP IV, CD26, EC 3.4.14.5). The application relates further to compounds that bind to the secondary binding site of DP IV
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816075 treating a human afflicted with condition characterized by elevated serum triglyceride or very low density lipoprotein (VLDL), comprising the step of administering an inhibitor of human delta-9 stearoyl-CoA desaturase (SCD1) activity; coronary artery disease, Type II diabetes, obesity
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 1298